跳至主要内容
临床试验/NCT03523546
NCT03523546进行中(未招募)不适用

Oncology Episode Payment Model in Hawaii

University of Pennsylvania1 个研究点 分布在 1 个国家目标入组 7 人开始时间: 2018年8月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
7
试验地点
1
主要终点
Composite quality score

研究概览

简要总结

The HMSA Cancer Episode Payment Model (CEM) is a payment model designed to test the effects of better care coordination on health outcomes and costs of care for Hawaii Medical Services Association (HMSA) members with cancer who receive chemotherapy.

详细描述

The CEM is designed to improve community health, to improve care coordination, quality, and appropriateness of care, to improve patient experience, and to implement a value-based incentive structure that appropriately rewards oncologists for cost-savings and sustained of improved quality of care.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Any oncologist who practices with Hawaii Oncology and is a participating provider.

排除标准

  • Any provider who does not practice with Hawaii Oncology.

研究组 & 干预措施

Cancer Episode Payment Model

Experimental

Oncologists in this arm will be paid for each member's episode of care. The episode of care is 6 months in duration. Oncologists will have the opportunity to receive performance-based payments based upon a set of 6 quality metrics.

干预措施: Cancer Episode Payment Model (CEM) (Other)

Fee for Service

No Intervention

Oncologists in this arm will not receive the intervention and will continue to be paid through fee-for-service.

结局指标

主要结局

Composite quality score

时间窗: 1 year

Quality metrics included in the oncology model will be compared across the two arms.

Episode cost

时间窗: 6 months

Total spending of oncology patients in the episode will be compared across the two arms.

Utilization of acute and specialty care

时间窗: 6 months

Total utilization of acute and specialty care of oncology patients in the episode will be compared across the two arms

次要结局

  • Quality of care at end of life(6 months)
  • Survival(one year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Amol Navathe

Principal Investigator

University of Pennsylvania

研究点 (1)

Loading locations...

相似试验